Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.67M Sell
7,590
-17,826
-70% -$4.23M 0.13% 170
2026
Q2
$7.15M Buy
25,416
+1,094
+4% +$276K 0.48% 55
2026
Q1
$5.95M Sell
24,322
-5,556
-19% -$1.5M 0.36% 71
2025
Q4
$8.85M Buy
29,878
+3,898
+15% +$1.17M 0.58% 43
2025
Q3
$7.33M Buy
25,980
+7,553
+41% +$1.98M 0.49% 49
2025
Q2
$5.43M Buy
18,427
+12,842
+230% +$3.31M 0.41% 65
2025
Q1
$1.39M Buy
5,585
+185
+3% +$45.3K 0.14% 139
2024
Q4
$1.19M Buy
5,400
+2,757
+104% +$614K 0.12% 151
2024
Q3
$584K Buy
2,643
+983
+59% +$193K 0.08% 142
2024
Q2
$294K Buy
+1,660
New +$288K 0.05% 170
2023
Q3
– Sell
-183
Closed -$24.5K – 509
2023
Q2
$24.5K Buy
+183
New +$23.6K 0.01% 414
2023
Q1
– Sell
-181
Closed -$25.4K – 454
2022
Q4
$25.4K Buy
+181
New +$25K 0.01% 291

Other funds holding IBM

Fiduciary Alliance's IBM Position: Q3 2026 in Review

Fiduciary Alliance reduced its IBM (IBM) stake by 70% in Q3 2026, selling an estimated $4.23M and leaving 7,590 shares worth $1.67M. The position accounts for 0.13% of the portfolio, ranked #170.

Fiduciary Alliance first reported a position in IBM in Q4 2022 and has held it in 12 quarters since. The position peaked at $8.85M in Q4 2025. 968 funds tracked by Wall St. Rank hold IBM as of Q3 2026.

  • Fiduciary Alliance held 7,590 shares of IBM worth $1.67M as of Q3 2026.
  • Fiduciary Alliance sold 17,826 IBM shares in Q3 2026, an estimated $4.23M.
  • IBM made up 0.13% of Fiduciary Alliance's portfolio in Q3 2026, its #170 holding.
  • Fiduciary Alliance first reported a position in IBM in Q4 2022 and has held it in 12 quarters since.
  • Fiduciary Alliance's IBM position peaked at $8.85M in Q4 2025.
  • 968 funds tracked by Wall St. Rank held IBM as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.